Health Care & Life Sciences » Pharmaceuticals | Millennium Pharmacon International

Millennium Pharmacon International | Income Statement

Fiscal year is January-December. All values IDR Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,310,244
1,437,668
1,707,613
1,970,114
2,110,825
2,376,183
Cost of Goods Sold (COGS) incl. D&A
1,193,591
1,310,878
1,555,576
1,806,147
1,935,684
2,170,750
Gross Income
116,653
126,789
152,038
163,967
175,141
205,433
SG&A Expense
85,898
94,685
107,406
115,839
123,923
139,527
EBIT
28,250
-
44,583
48,147
50,713
65,691
Non Operating Income/Expense
662
129
2,080
267
1,391
2,585
Interest Expense
13,741
21,951
26,298
30,750
28,785
34,663
Pretax Income
15,443
10,277
16,774
17,248
20,674
28,591
Income Tax
5,195
2,937
4,867
6,142
6,494
9,147
Consolidated Net Income
10,247
7,340
11,907
11,106
14,180
19,444
Net Income
10,247
7,340
11,907
11,106
14,180
19,444
Net Income After Extraordinaries
10,247
7,340
11,907
11,106
14,180
19,444
Net Income Available to Common
10,247
7,340
11,907
11,106
14,180
19,444
EPS (Basic)
13.81
9.89
16.06
14.98
18.89
15.26
Basic Shares Outstanding
742
742
742
742
751
1,274
EPS (Diluted)
13.81
9.89
16.05
14.97
18.89
15.26
Diluted Shares Outstanding
742
742
742
742
751
1,274
EBITDA
32,059
36,496
49,846
53,422
55,171
70,414
Other Operating Expense
2,505
353
49
19
504
215
Non-Operating Interest Income
271
348
569
118
137
149

About Millennium Pharmacon International

View Profile
Address
Panin Bank Centre
Jakarta JK 10270
Indonesia
Employees -
Website http://www.mpi-indonesia.co.id
Updated 07/08/2019
PT Millennium Pharmacon International Tbk engages in the distribution and trading of pharmaceutical products, food supplements, and diagnostic products. It operates through the following segments: Medicines, Food Supplements, and Diagnostic Products. The company's products include Amoxicillin, Asam Mefenamat, and Baraka Softgel.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.